Viewing StudyNCT05082025

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 4:46 PM
Last Modification Date: 2024-10-26 @ 2:15 PM
Study NCT ID: NCT05082025
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-10
First Post: 2021-09-02
Brief Title: Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER andor PR Cancers With PI3K PIK3CA PIK3R1 andor PTEN Alterations
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Endometrial Cancer
Ovarian Cancer
Keywords: